• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄连解毒汤治疗中医“上火”证的干预研究

Huanglian Jiedu Decoction in the Treatment of the Traditional Chinese Medicine Syndrome "Shanghuo"-An Intervention Study.

作者信息

Luo Keke, Zhao Haiyu, Bian Baolin, Wei Xiaolu, Si Nan, Brantner Adelheid, Fan Xiaorui, Gu Xinru, Zhou Yanyan, Wang Hongjie

机构信息

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.

出版信息

Front Pharmacol. 2021 Apr 30;12:616318. doi: 10.3389/fphar.2021.616318. eCollection 2021.

DOI:10.3389/fphar.2021.616318
PMID:33995016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8120301/
Abstract

"Shanghuo" ("excessive internal heat") is caused by exuberant endogenous fire, which does not have a comprehensive and systematic traditional Chinese medicine theory. In previous study, we had evaluated the therapeutic effect of Huanglian Jiedu Decoction (HLJDD) (granule) on patients with "Shanghuo", however, the specific mechanism was not clear, which need further exploration. To explain its intervention mechanism, we select 57 patients with oral diseases caused by "Shanghuo" and 20 health volunteers to divide into oral disease group, HLJDD intervention group and healthy control group. Firstly, biochemical indicators before and after HLJDD intervention are detected, such as inflammatory factors, oxidative stress factors and energy metabolism factors. The results exhibit that HLJDD significantly decreases indicators succinic acid ( < 0.001); tumor necrosis factor-alpha, adenosine triphosphate, citric acid ( < 0.01); interleukin-8 (IL-8), 4-hydroxynonenal, pyruvic acid, lactate dehydrogenase ( < 0.05). The levels of glucocorticoid, adrenocorticotropic hormone ( < 0.01); lactic acid, IL-4, IL-10 ( < 0.05) significantly increase after HLJDD intervention. In addition, we adopt multi-omics analysis approach to investigate the potential biomarkers. Nontargeted metabolomics demonstrate that the levels of 7 differential metabolites approach that in the healthy control group after HLJDD intervention, which are correlated with histidine metabolism, beta-alanine metabolism and sphingolipid metabolism through metabolic pathway analysis. Targeted lipidomics results and receiver operating characteristic curve analysis show that 13 differential lipids are identified in the three groups mainly focuse on lysophosphatidylcholines, lysophosphatidylethanolamines. Finally, the network associations of those differential biomarkers reveal the regulation of adenosine triphosphate and tricarboxylic acid cycle play essential role in the therapeutic effect mechanism of HLJDD in "Shanghuo". The study has laid the foundation for further revealing the mechanism and finding clinical biomarkers related to "Shanghuo".

摘要

“上火”是由内生火热过盛引起的,目前尚无全面系统的中医理论。在之前的研究中,我们评估了黄连解毒汤(颗粒)对“上火”患者的治疗效果,然而,具体机制尚不清楚,有待进一步探索。为解释其干预机制,我们选取57例由“上火”引起口腔疾病的患者和20名健康志愿者,分为口腔疾病组、黄连解毒汤干预组和健康对照组。首先,检测黄连解毒汤干预前后的生化指标,如炎症因子、氧化应激因子和能量代谢因子。结果显示,黄连解毒汤可显著降低琥珀酸(<0.001)、肿瘤坏死因子-α、三磷酸腺苷、柠檬酸(<0.01)、白细胞介素-8(IL-8)、4-羟基壬烯醛、丙酮酸、乳酸脱氢酶(<0.05)的指标水平。黄连解毒汤干预后,糖皮质激素、促肾上腺皮质激素(<0.01)、乳酸、IL-4、IL-10(<0.05)的水平显著升高。此外,我们采用多组学分析方法来研究潜在的生物标志物。非靶向代谢组学表明,黄连解毒汤干预后7种差异代谢物的水平接近健康对照组,通过代谢途径分析,这些代谢物与组氨酸代谢、β-丙氨酸代谢和鞘脂代谢相关。靶向脂质组学结果和受试者工作特征曲线分析表明,三组中鉴定出13种差异脂质,主要集中在溶血磷脂酰胆碱、溶血磷脂酰乙醇胺。最后,这些差异生物标志物的网络关联揭示了三磷酸腺苷和三羧酸循环的调节在黄连解毒汤治疗“上火”的作用机制中起重要作用。该研究为进一步揭示其机制和寻找与“上火”相关的临床生物标志物奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/081edb3287a2/fphar-12-616318-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/d35ac44b9317/fphar-12-616318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/82f51f3eed88/fphar-12-616318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/d548236f5235/fphar-12-616318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/cebfc89fe417/fphar-12-616318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/de62033549d4/fphar-12-616318-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/96e7d3785c44/fphar-12-616318-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/b85571a69431/fphar-12-616318-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/63b1107abbf3/fphar-12-616318-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/388a6b376c29/fphar-12-616318-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/22b1df14b454/fphar-12-616318-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/88985a6c6722/fphar-12-616318-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/081edb3287a2/fphar-12-616318-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/d35ac44b9317/fphar-12-616318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/82f51f3eed88/fphar-12-616318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/d548236f5235/fphar-12-616318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/cebfc89fe417/fphar-12-616318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/de62033549d4/fphar-12-616318-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/96e7d3785c44/fphar-12-616318-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/b85571a69431/fphar-12-616318-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/63b1107abbf3/fphar-12-616318-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/388a6b376c29/fphar-12-616318-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/22b1df14b454/fphar-12-616318-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/88985a6c6722/fphar-12-616318-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ab/8120301/081edb3287a2/fphar-12-616318-g012.jpg

相似文献

1
Huanglian Jiedu Decoction in the Treatment of the Traditional Chinese Medicine Syndrome "Shanghuo"-An Intervention Study.黄连解毒汤治疗中医“上火”证的干预研究
Front Pharmacol. 2021 Apr 30;12:616318. doi: 10.3389/fphar.2021.616318. eCollection 2021.
2
Huanglian Jiedu Wan intervened with "Shi-Re Shanghuo" syndrome through regulating immune balance mediated by biomarker succinate.黄连解毒丸通过调节琥珀酸介导的生物标志物相关的免疫平衡干预“湿-热-上火”证。
Clin Immunol. 2024 Jan;258:109861. doi: 10.1016/j.clim.2023.109861. Epub 2023 Dec 6.
3
[Biomarkers related to cognitive dysfunction in APP/PS1 mice based on non-targeted metabonomics and intervention mechanism of Huanglian Jiedu Decoction].基于非靶向代谢组学的APP/PS1小鼠认知功能障碍相关生物标志物及黄连解毒汤干预机制
Zhongguo Zhong Yao Za Zhi. 2022 Nov;47(22):6117-6126. doi: 10.19540/j.cnki.cjcmm.20220705.401.
4
Untargeted metabolomics and lipidomics uncovering the cardioprotective effects of Huanglian Jiedu Decoction on pathological cardiac hypertrophy and remodeling.非靶向代谢组学和脂质组学揭示黄连解毒汤对病理性心肌肥厚和重构的心脏保护作用。
J Ethnopharmacol. 2021 Apr 24;270:113646. doi: 10.1016/j.jep.2020.113646. Epub 2020 Nov 29.
5
Study on the Molecular Basis of Huanglian Jiedu Decoction Against Atopic Dermatitis Integrating Chemistry, Biochemistry, and Metabolomics Strategies.黄连解毒汤治疗特应性皮炎的分子基础研究:整合化学、生物化学和代谢组学策略
Front Pharmacol. 2021 Dec 14;12:770524. doi: 10.3389/fphar.2021.770524. eCollection 2021.
6
Systems pharmacology, proteomics and in vivo studies identification of mechanisms of cerebral ischemia injury amelioration by Huanglian Jiedu Decoction.系统药理学、蛋白质组学及体内研究:黄连解毒汤改善脑缺血损伤机制的鉴定
J Ethnopharmacol. 2022 Jul 15;293:115244. doi: 10.1016/j.jep.2022.115244. Epub 2022 Apr 1.
7
[Clinical application value of Huanglian Jiedu Pills in improving syndrome of excess heat and fire toxin based on phase Ⅱ clinical trial study on plasma ATP, 4-HNE, and ACTH levels].基于黄连解毒丸对血浆ATP、4-HNE及ACTH水平影响的Ⅱ期临床试验研究探讨黄连解毒丸改善实热火毒证的临床应用价值
Zhongguo Zhong Yao Za Zhi. 2023 Feb;48(4):1124-1131. doi: 10.19540/j.cnki.cjcmm.20221008.502.
8
[Pharmacodynamics of Huanglian Jiedu decoction in Alzheimer's disease (AD) model rats and effect on improvement of inflammation microenvironment in brain].黄连解毒汤对阿尔茨海默病(AD)模型大鼠的药效学及对改善脑内炎症微环境的作用
Zhongguo Zhong Yao Za Zhi. 2018 Jul;43(14):3006-3011. doi: 10.19540/j.cnki.cjcmm.2018.0092.
9
Huanglian Jiedu decoction inhibits vascular smooth muscle cell-derived foam cell formation by activating autophagy via suppressing P2RY12.黄连解毒汤通过抑制 P2RY12 激活自噬抑制血管平滑肌细胞源性泡沫细胞形成。
J Ethnopharmacol. 2024 Jun 28;328:118125. doi: 10.1016/j.jep.2024.118125. Epub 2024 Mar 30.
10
Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional Chinese medicine Huanglian Jiedu decoction.黄连解毒汤对2型糖尿病大鼠和正常大鼠灌胃给药后黄芩苷和汉黄芩苷的比较药代动力学研究
J Ethnopharmacol. 2014 Aug 8;155(1):334-42. doi: 10.1016/j.jep.2014.05.033. Epub 2014 Jun 5.

引用本文的文献

1
Research Progress on the Correlation Between Hypertension and Gut Microbiota.高血压与肠道微生物群相关性的研究进展
J Multidiscip Healthc. 2024 May 16;17:2371-2387. doi: 10.2147/JMDH.S463880. eCollection 2024.
2
Efficacy and mechanism of Jiedu Tongluo Tiaogan Formula in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease: Study protocol for a parallel-armed, randomized controlled trial.解毒通络调肝方治疗2型糖尿病合并非酒精性脂肪性肝病的疗效及机制:一项平行双臂随机对照试验的研究方案
Front Pharmacol. 2022 Aug 12;13:924021. doi: 10.3389/fphar.2022.924021. eCollection 2022.
3
Variation in the Efficacy of Anti-Ulcerative Colitis Treatments Reveals the Conflict Between Precipitating Compatibility of Traditional Chinese Medicine and Modern Technology: A Case of Scutellaria-Coptis.

本文引用的文献

1
Metabolic disturbance in Korean red ginseng-induced "Shanghuo" (excessive heat).韩国红参引起的“上火”(过热)中的代谢紊乱。
J Ethnopharmacol. 2020 May 10;253:112604. doi: 10.1016/j.jep.2020.112604. Epub 2020 Jan 21.
2
Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations.黄连解毒汤:植物化学、药理学及药代动力学研究综述
Chin Med. 2019 Dec 18;14:57. doi: 10.1186/s13020-019-0277-2. eCollection 2019.
3
"Shanghuo" increases disease susceptibility: Modern significance of an old TCM theory.
抗溃疡性结肠炎治疗效果的差异揭示了中药配伍与现代技术之间的矛盾:以黄芩-黄连为例
Front Pharmacol. 2022 Apr 20;13:819851. doi: 10.3389/fphar.2022.819851. eCollection 2022.
上火增加疾病易感性:中医理论的现代意义。
J Ethnopharmacol. 2020 Mar 25;250:112491. doi: 10.1016/j.jep.2019.112491. Epub 2019 Dec 18.
4
[Mechanisms of tanshinone Ⅱ_A in reducing 4-HNE-induced hepatocyte damage by activating PPARα].[丹参酮ⅡA通过激活PPARα减轻4-羟基壬烯醛诱导的肝细胞损伤的机制]
Zhongguo Zhong Yao Za Zhi. 2019 May;44(9):1862-1868. doi: 10.19540/j.cnki.cjcmm.20190305.002.
5
The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis.循环修饰脂质在动脉粥样硬化中的致动脉粥样硬化作用。
Int J Mol Sci. 2019 Jul 20;20(14):3561. doi: 10.3390/ijms20143561.
6
The dynamic uptake and release of SOD3 from intracellular stores in macrophages modulates the inflammatory response.巨噬细胞细胞内储存库中 SOD3 的动态摄取和释放调节炎症反应。
Redox Biol. 2019 Sep;26:101268. doi: 10.1016/j.redox.2019.101268. Epub 2019 Jul 2.
7
Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration.糖皮质激素在创伤时抑制巨噬细胞向促炎表型分化,而不影响其迁移。
Dis Model Mech. 2019 May 30;12(5):dmm037887. doi: 10.1242/dmm.037887.
8
L-Lysine as the Molecule Influencing Selective Brain Activity in Pain-Induced Behavior of Rats.赖氨酸作为影响大鼠疼痛诱导行为中选择性脑活动的分子。
Int J Mol Sci. 2019 Apr 17;20(8):1899. doi: 10.3390/ijms20081899.
9
Evaluation of salivary tumour necrosis factor-alpha in patients with recurrent aphthous stomatitis.复发性阿弗他口炎患者唾液肿瘤坏死因子-α的评估
Eur Oral Res. 2018 Sep;52(3):157-161. doi: 10.26650/eor.2018.543. Epub 2018 Sep 1.
10
Integrating Targeted and Untargeted Metabolomics to Investigate the Processing Chemistry of Polygoni Multiflori Radix.整合靶向和非靶向代谢组学以研究何首乌的炮制化学。
Front Pharmacol. 2018 Aug 28;9:934. doi: 10.3389/fphar.2018.00934. eCollection 2018.